Securities Fraud Class Action Funding: PSLRA, Loss Causation, and Market Efficiency

How funders navigate heightened pleading, loss causation, and the efficient market presumption.

Securities fraud class action funding finances representative litigation on behalf of investors who allege they were harmed by material misrepresentations affecting securities prices. These cases are among the most procedurally demanding in federal litigation, governed by the heightened requirements of the Private Securities Litigation Reform Act, and they require substantial capital to prosecute through the gauntlet of motion practice, class certification, and expert-intensive damages analysis. The combination of high stakes and high cost makes them well suited to funding.

The PSLRA imposes heightened pleading standards designed to screen out weak securities claims at the outset. A plaintiff must plead the alleged misrepresentations with particularity and must allege facts giving rise to a strong inference of scienter, the defendant's intent to deceive or recklessness. These requirements make the motion to dismiss a critical and often decisive stage. A claim that survives dismissal has cleared a meaningful hurdle, and funders weigh the strength of the scienter allegations heavily in underwriting.

The efficient market presumption underlies most securities class actions. To certify a class on a fraud-on-the-market theory, plaintiffs must show that the security traded in an efficient market, such that the alleged misrepresentations were reflected in its price and reliance can be presumed classwide. Defendants challenge market efficiency and price impact through competing expert testimony, and the certification decision often turns on this contest. Funders model the certification probability as a central driver of expected value.

Loss causation and damages complete the analysis. Under Dura Pharmaceuticals, plaintiffs must show that the alleged fraud, rather than other market factors, caused their losses, typically through an event study isolating the price impact of corrective disclosures. These analyses are highly expert-dependent and contestable. Funders scrutinize the loss causation theory and the damages methodology, discounting the headline figures for the realistic probability of establishing causation and surviving the certification and merits challenges.

Criterica Capital funds securities fraud class actions, assessing dismissal, certification, and loss causation risk against outcome data drawn from 106M+ court records, including the disposition history of comparable securities dockets. This grounds our underwriting in observed outcomes. Firms prosecuting securities class actions can contact our institutional team to discuss funding.

Discuss your matter with our institutional team.